Searched for: in-biosketch:true
person:perryr01
Efficacy and safety of fenfluramine in autistic children
Campbell M; Adams P; Small AM; Curren EL; Overall JE; Anderson LT; Lynch N; Perry R
PMID: 3053609
ISSN: 0890-8567
CID: 66981
Tardive and withdrawal dyskinesia in autistic children: a prospective study
Campbell, M; Adams, P; Perry, R; Spencer, E K; Overall, J E
PMID: 3212157
ISSN: 0048-5764
CID: 165496
PHARMACOTHERAPY IN INFANTILE-AUTISM - EFFICACY AND SAFETY [Meeting Abstract]
Campbell, M; Small, AM; Perry, R; Green, WH
ISI:A1987G703100958
ISSN: 0020-7454
CID: 31238
Cholinesterase activities in blood in infantile autism
Deutsch, S I; Milstoc, M; Platovsky, G; Wolsky, B B; Perry, R; Green, W H
PMID: 3814674
ISSN: 0006-3223
CID: 93042
The efficacy and safety of fenfluramine in autistic children: preliminary analysis of a double-blind study
Campbell M; Small AM; Palij M; Perry R; Polonsky BB; Lukashok D; Anderson LT
PMID: 3602307
ISSN: 0048-5764
CID: 66983
A taxometric method for diagnosis of tardive dyskinesia
Golden, R R; Campbell, M; Perry, R
A taxometric method for diagnosis of drug-induced tardive dyskinesia is described. The method, using items from the Abnormal Involuntary Movement Scale (AIMS) as indicators of the syndrome, is applied in a sample of children diagnosed earlier as autistic and participating in an ongoing treatment program. The method includes procedures for estimation of the prevalence rate of the syndrome and the valid positive and false positive rates for each indicator of the syndrome and it includes tests (referred to as "consistency tests") for checking the internal validity or goodness-of-fit of the statistical model. The agreement of the taxometric classification with that obtained by using criteria suggested by Schooler and Kane was very good. In general, the results were encouraging enough to warrant further study of this kind of method for the detection and diagnosis of tardive dyskinesia.
PMID: 2890764
ISSN: 0022-3956
CID: 165493
An open study of fenfluramine in hospitalized young autistic children
Campbell, M; Perry, R; Polonsky, B B; Deutsch, S I; Palij, M; Lukashok, D
PMID: 3804962
ISSN: 0162-3257
CID: 165499
Plasma growth hormone response to insulin-induced hypoglycemia in infantile autism: a pilot study
Deutsch, S I; Campbell, M; Perry, R; Green, W H; Poland, R E; Rubin, R T
Plasma growth hormone responses to insulin-induced hypoglycemia were examined in eight preschool-age autistic children. Six of these children were examined on two separate occasions: during the period of baseline evaluation and after 4 weeks of daily haloperidol administration. On at least one occasion, half of this small sample exhibited persistent elevation of growth hormone levels, with a failure to return to baseline values over the course of a 135-minute period postinsulin infusion. These data are consistent with the occurrence of hypothalamic dysfunction in subgroups of autistic children. Short-term administration of haloperidol did not diminish the ability of the pituitary to secrete growth hormone in response to insulin-induced hypoglycemia
PMID: 2870051
ISSN: 0162-3257
CID: 120764
Short-term efficacy and safety of fenfluramine in hospitalized preschool-age autistic children: an open study
Campbell, M; Deutsch, S I; Perry, R; Wolsky, B B; Palij, M
PMID: 3726060
ISSN: 0048-5764
CID: 165498
Neuroleptic-related dyskinesias in autistic children: a prospective study
Perry R; Campbell M; Green WH; Small AM; Die Trill ML; Meiselas K; Golden RR; Deutsch SI
PMID: 3885290
ISSN: 0048-5764
CID: 63252